AnthroTronix and Nview Health Collaboration Powers Seamless Assessment of Cognition and Behavioral Health
Partnership Provides Consistent Measurement of Cognitive and Behavioral Health in One Place
St. Augustine, FL, May 25, 2017 --(PR.com)-- AnthroTronix and Nview Health announced today they have partnered to combine two technologies to test both a person’s cognitive function and their behavioral health. Used together, these technologies can provide healthcare practitioners with better insight into a person’s complete behavioral health and wellness.
AnthroTronix’s DANA is an FDA cleared clinical neurocognitive assessment tool that uses a smartphone or tablet to measure and monitor changes in a person’s brain/cognitive function. The app can help clinicians track cognitive function for conditions such as depression, dementia/Alzheimer’s Disease, and Post-Traumatic Stress Disorder.
“Cognitive function and behavioral health are closely linked,” said AnthroTronix CEO Cori Lathan. “Our behavioral health status effects our cognitive efficiency so to get a clear picture of a person’s brain health, it’s important to test both. Our partnership with Nview Health now enables healthcare providers the ability to do that.”
Nview’s diagnostic instrument, the M.I.N.I. - Mini International Neuropsychiatric Interview - is a short, structured diagnostic interview designed to evaluate the most common DSM-5 and ICD-10 psychiatric disorders. It enables healthcare professionals to rapidly deliver a behavioral health diagnosis and has been used in patient care and clinical research for more than 25 years.
“Our partnership with AnthroTronix now allows us to measure an individual’s cognitive status, which is essential to the care and treatment of behavioral health disorders,” said Nview Health Chief Executive Officer and Co-Founder Thomas R. Young, M.D.
About Nview Health
Nview is a behavioral health technology that enables healthcare professionals to rapidly deliver the right diagnosis, resulting in the right treatment, at the right time. Our signature product The M.I.N.I. enables providers to deliver validated diagnostic behavioral health screens, interviews, outcome tracking, and billable services to patients in a simple and easy-to-use platform. Nview’s suicidality assessment and tracking tools offer providers a means of reducing suicide in their populations. To learn more please visit our website: www.NviewHealth.com, follow us on Twitter at @NviewHealth and Facebook at @nviewHEALTH, or connect with us on LinkedIn.
About AnthroTronix
AnthroTronix, an engineering research and development company, produces human-centered technologies that advance health, communication, education, and defense. We develop innovative, research-based technologies that influence change and enhance lives around the world. Our company has been recognized among Inc. Magazine’s “5000 Fastest Growing Companies" and selected by the World Economic Forum as a Technology Pioneer company. For more information on us, visit www.atinc.com, follow us on Twitter at @AnthroTronix, or connect with us on LinkedIn.
AnthroTronix’s DANA is an FDA cleared clinical neurocognitive assessment tool that uses a smartphone or tablet to measure and monitor changes in a person’s brain/cognitive function. The app can help clinicians track cognitive function for conditions such as depression, dementia/Alzheimer’s Disease, and Post-Traumatic Stress Disorder.
“Cognitive function and behavioral health are closely linked,” said AnthroTronix CEO Cori Lathan. “Our behavioral health status effects our cognitive efficiency so to get a clear picture of a person’s brain health, it’s important to test both. Our partnership with Nview Health now enables healthcare providers the ability to do that.”
Nview’s diagnostic instrument, the M.I.N.I. - Mini International Neuropsychiatric Interview - is a short, structured diagnostic interview designed to evaluate the most common DSM-5 and ICD-10 psychiatric disorders. It enables healthcare professionals to rapidly deliver a behavioral health diagnosis and has been used in patient care and clinical research for more than 25 years.
“Our partnership with AnthroTronix now allows us to measure an individual’s cognitive status, which is essential to the care and treatment of behavioral health disorders,” said Nview Health Chief Executive Officer and Co-Founder Thomas R. Young, M.D.
About Nview Health
Nview is a behavioral health technology that enables healthcare professionals to rapidly deliver the right diagnosis, resulting in the right treatment, at the right time. Our signature product The M.I.N.I. enables providers to deliver validated diagnostic behavioral health screens, interviews, outcome tracking, and billable services to patients in a simple and easy-to-use platform. Nview’s suicidality assessment and tracking tools offer providers a means of reducing suicide in their populations. To learn more please visit our website: www.NviewHealth.com, follow us on Twitter at @NviewHealth and Facebook at @nviewHEALTH, or connect with us on LinkedIn.
About AnthroTronix
AnthroTronix, an engineering research and development company, produces human-centered technologies that advance health, communication, education, and defense. We develop innovative, research-based technologies that influence change and enhance lives around the world. Our company has been recognized among Inc. Magazine’s “5000 Fastest Growing Companies" and selected by the World Economic Forum as a Technology Pioneer company. For more information on us, visit www.atinc.com, follow us on Twitter at @AnthroTronix, or connect with us on LinkedIn.
Contact
Nview Health
Kristi R. Stovall
312.498.4078
nviewhealth.com
Kristi R. Stovall
312.498.4078
nviewhealth.com
Contact
Categories